The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Incidence and Clinical Impact of Major Bleeding Following Left Atrial Appendage Occlusion: Insights from the Amplatzer™ Amulet™ LAA Occluder Observational Study

DOI: 10.4244/EIJ-D-20-01309

1. Department of Cardiology, Centre Hospitalier Universitaire de Charleroi, Charleroi, Belgium, Belgium
2. Department of Cardiology, Rigshospitalet, Copenhagen, Denmark
3. Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark
4. Arrhythmology and Cardiac Pacing Unit; Ospedale San Raffaele, Milan Italy
5. Department of Interventional and Diagnostic Cardiology, Fondazione Toscana Gabriele Monasterio, Pisa, Italy
6. Department of Cardiology, Harzklinikum Dorothea Christiane Erxleben GmbH, Quedlinburg, Germany
7. Heart Center, Turku University Hospital, Turku, Finland
8. Interventional Cardiology Unit, Ospedale San Raffaele, Milan, Italy
9. Department of Medicine, Queen Mary Hospital, Hong Kong
10. Hospital Clinic de Barcelona, Barcelona, Spain
11. Structural Heart Clinical Affairs, Abbott, St. Paul, Minnesota, USA
12. Institute for Medical Informatics, Biometry and Epidemiology, Medical Faculty of the University Duisburg-Essen, Essen, Germany
13. Cardioangiologisches Centrum Bethanien, Agaplesion Markus Krankenhaus, Medizinische Klinik 3 – Kardiologie, Frankfurt, Germany
Disclaimer:

As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention and external reviewers - has been published immediately upon acceptance as it was received in the last round of revision. The content of this article is the responsibility of the authors.

Please note that supplementary movies are not available online at this stage. Once a paper is published in its edited and formatted form, it will be accompanied online by any supplementary movies.

To read the full content of this article, please log in to download the PDF.

Background: Major bleeding (MB) events are independent predictors of mortality after cardiac interventional procedures. The clinical relevance of MB following left atrial appendage occlusion (LAAO) remains unclear.

Aims: This study aimed to investigate the incidence and clinical impact of MB after LAAO in a real-world population at high-risk for bleeding and contraindicated to anticoagulation.

Methods: The 2-year results of the Amplatzer™ Amulet™ Occluder Observational Study were analyzed.  An independent committee adjudicated MBs according to the Bleeding Academic Research Consortium scale.  Cox proportional hazards regression identified variables associated with MB events and mortality.

Results: The MB rate was 7.2%/year, with a rate of 10.1%/year during year one, decreasing to 4.0%/year over year two.  The most common bleeding location was gastrointestinal, accounting for 48% of MBs. Pre-LAAO MB was associated with an increased risk for post-LAAO MB (HR 2.34; 95% CI 1.37-3.99). The occurrence of post-LAAO MB was associated with increased mortality (37.3% vs 12.7%; p<0.0001), mainly driven by events occurring beyond the peri-procedural period.  The annualized rate of ischemic stroke or TIA was similar in patients with and without MB (2.3% vs 3.3%; p=0.446). MB post-LAAO was a strong independent predictor of mortality (HR 3.07; 95% CI 2.15-4.40).

Conclusions: In real-world patients at high bleeding risk, MB following LAAO was not uncommon and associated with a significant increase in mortality, without increasing the risk of stroke.

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Coronary interventions 2020: the year in review